Patent: 8,460,693
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Patent: 8,460,693
Title: | Intraluminal device with a coating containing synthetic fish oil and a therapeutic agent |
Abstract: | The invention relates to an intraluminal device, in particular an intraluminal prosthesis, shunt, catheter or local drug delivery device. In order to increase the bio-compatibility of this device, it is provided with at least one coating. The coating contains a therapeutic agent which is comprised in a matrix that sticks to the intraluminal device. Instead of being formed by a little bio-compatible polymer, the matrix is formed by a bio-compatible oil or fat, such as cod-liver oil or olive oil. Preferably, the bio-compatible oil or fat further comprises alfa-tocopherol. |
Inventor(s): | Dhondt; Maria (Nazareth, BE), De Scheerder; Ivan (Herent, BE), Jacobs; Pierre (Gooik, BE), Martens; Johan (Huldenberg, BE) |
Assignee: | Atrium Medical Corporation (Hudson, NH) |
Application Number: | 10/494,892 |
Patent Claims: | see list of patent claims |
Details for Patent 8,460,693
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Hoffmann-la Roche Inc. | ZENAPAX | daclizumab | Injection | 103749 | 12/10/1997 | ⤷ Try a Trial | 2021-11-08 |
Biogen Inc. | ZINBRYTA | daclizumab | Injection | 761029 | 05/27/2016 | ⤷ Try a Trial | 2021-11-08 |
Biogen Inc. | ZINBRYTA | daclizumab | Injection | 761029 | 05/26/2017 | ⤷ Try a Trial | 2021-11-08 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |